117 related articles for article (PubMed ID: 38582630)
21. Value of diffusion tensor imaging in differentiating malignant from benign parotid gland tumors.
Takumi K; Fukukura Y; Hakamada H; Ideue J; Kumagae Y; Yoshiura T
Eur J Radiol; 2017 Oct; 95():249-256. PubMed ID: 28987676
[TBL] [Abstract][Full Text] [Related]
22. [Performance of the magnetic resonance imaging in parotid gland tumor histopathology].
Masmoudi M; Hasnaoui M; Guizani R; Lahmar R; Jerbi S; Mighri K
Pan Afr Med J; 2021; 39():10. PubMed ID: 34178238
[TBL] [Abstract][Full Text] [Related]
23. Multispectral optoacoustic tomography of benign parotid tumors in vivo: a prospective observational pilot study.
Kouka M; Waldner M; Guntinas-Lichius O
Sci Rep; 2024 May; 14(1):10597. PubMed ID: 38719924
[TBL] [Abstract][Full Text] [Related]
24. Warthin's tumor of parotid gland on Tc-99m pertechnetate scintigraphy with lemon juice stimulation: Tc-99m uptake, size, and pathologic correlation.
Miyake H; Matsumoto A; Hori Y; Takeoka H; Kiyosue H; Hori Y; Mori H; Ueyama S; Kashima K
Eur Radiol; 2001; 11(12):2472-8. PubMed ID: 11734943
[TBL] [Abstract][Full Text] [Related]
25. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.
Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
Sci Rep; 2022 Apr; 12(1):5947. PubMed ID: 35396374
[TBL] [Abstract][Full Text] [Related]
26. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
[TBL] [Abstract][Full Text] [Related]
27. Parotid tumors: differentiation of benign and malignant tumors with quantitative sonographic analyses.
Yonetsu K; Ohki M; Kumazawa S; Eida S; Sumi M; Nakamura T
Ultrasound Med Biol; 2004 May; 30(5):567-74. PubMed ID: 15183220
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of qualitative and radiomics approach to parotid gland tumors: which is the added benefit of texture analysis?
Vernuccio F; Arnone F; Cannella R; Verro B; Comelli A; Agnello F; Stefano A; Gargano R; Rodolico V; Salvaggio G; Lagalla R; Midiri M; Lo Casto A
Br J Radiol; 2021 Dec; 94(1128):20210340. PubMed ID: 34591597
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of parotid gland tumors using apparent diffusion coefficient, texture features, and their combination.
Muraoka H; Kaneda T; Kondo T; Okada S; Tokunaga S
Dentomaxillofac Radiol; 2023 Apr; 52(4):20220404. PubMed ID: 37015250
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of parotid gland lesions with standard ultrasound, color duplex sonography, sonoelastography, and acoustic radiation force impulse imaging - a pilot study.
Mansour N; Stock KF; Chaker A; Bas M; Knopf A
Ultraschall Med; 2012 Jun; 33(3):283-8. PubMed ID: 22504938
[TBL] [Abstract][Full Text] [Related]
31. Pleomorphic adenoma and adenolymphoma in ultrasonography.
Zajkowski P; Jakubowski W; Białek EJ; Wysocki M; Osmólski A; Serafin-Król M
Eur J Ultrasound; 2000 Sep; 12(1):23-9. PubMed ID: 10996767
[TBL] [Abstract][Full Text] [Related]
32. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.
Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS
BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615
[TBL] [Abstract][Full Text] [Related]
33. Grading Clear Cell Renal Cell Carcinoma Grade Using Diffusion Relaxation Correlated MR Spectroscopic Imaging.
Dai Y; Hu W; Wu G; Wu D; Zhu M; Luo Y; Wang J; Zhou Y; Hu P
J Magn Reson Imaging; 2024 Feb; 59(2):699-710. PubMed ID: 37209407
[TBL] [Abstract][Full Text] [Related]
34. Influence of post-label delay time on the performance of 3D pseudo-continuous arterial spin labeling magnetic resonance imaging in the characterization of parotid gland tumors.
Hu H; Chen L; Zhu LN; Chen W; Su GY; Dou W; Bu SS; Wu FY; Xu XQ
Eur Radiol; 2022 Feb; 32(2):1087-1094. PubMed ID: 34347158
[TBL] [Abstract][Full Text] [Related]
35. Gray scale and Doppler ultrasonography of the benign tumors of parotid gland (pleomorphic adenoma and Warthin's tumor). Pictorial essay.
Fodor D; Pop S; Maniu A; Cosgaria M
Med Ultrason; 2010 Sep; 12(3):238-44. PubMed ID: 21203603
[TBL] [Abstract][Full Text] [Related]
36. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
[TBL] [Abstract][Full Text] [Related]
37. Parotid Warthin's tumor: novel MR imaging score as diagnostic indicator.
Luna LP; Coffey W; Alvin MD; Shanechi AM; Sankaran N; Rodriguez EF; Naeem Z; Aygun N; Khan M
Clin Imaging; 2022 Jan; 81():9-14. PubMed ID: 34598007
[TBL] [Abstract][Full Text] [Related]
38. Correlation between MRI (DWI and DCE) and cellularity of parotid gland pleomorphic adenomas.
Monestier L; Del Grande J; Haddad R; Santini L; Michel J; Varoquaux A; Fakhry N
Eur Arch Otorhinolaryngol; 2024 May; 281(5):2655-2665. PubMed ID: 38498193
[TBL] [Abstract][Full Text] [Related]
39. Non-enhanced MRI in combination with color Doppler flow imaging for improving diagnostic accuracy of parotid gland lesions.
Zhang W; Zuo Z; Luo N; Liu L; Jin G; Liu J; Su D
Eur Arch Otorhinolaryngol; 2018 Apr; 275(4):987-995. PubMed ID: 29430614
[TBL] [Abstract][Full Text] [Related]
40. Value of pre-/post-contrast-enhanced T1 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging in differentiating parotid gland tumors.
Wen B; Zhang Z; Fu K; Zhu J; Liu L; Gao E; Qi J; Zhang Y; Cheng J; Qu F; Zhu J
Eur J Radiol; 2023 May; 162():110748. PubMed ID: 36905715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
